Team:Paris/August 12
From 2008.igem.org
(Difference between revisions)
(→Electrophoresis) |
(→Electrophoresis) |
||
Line 213: | Line 213: | ||
|align="center"|positive control | |align="center"|positive control | ||
|align="center"|negative control | |align="center"|negative control | ||
- | |colspan="4"|L128 (pFlgA) | + | |colspan="4"|L128 ('''pFlgA''') |
- | |colspan="4"|L129 (pFlgB) | + | |colspan="4"|L129 ('''pFlgB''') |
- | |colspan="4"|L130 (pFlhB) | + | |colspan="4"|L130 ('''pFlhB''') |
|align="center"|100 bp DNA ladder | |align="center"|100 bp DNA ladder | ||
|- | |- | ||
Line 251: | Line 251: | ||
|- | |- | ||
|align="center"|'''expected size''' | |align="center"|'''expected size''' | ||
- | |align="center"| | + | |align="center"| |
|align="center"|1161 bp | |align="center"|1161 bp | ||
|align="center"|0 bp | |align="center"|0 bp | ||
Line 257: | Line 257: | ||
|colspan="4"|1339 bp | |colspan="4"|1339 bp | ||
|colspan="4"|1338 bp | |colspan="4"|1338 bp | ||
- | |align="center"| | + | |align="center"| |
+ | |- | ||
+ | |align="center"|'''measured size''' | ||
+ | |align="center"| | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|0 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|1,3 kb | ||
+ | |align="center"|1,3 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|0 kb | ||
+ | |align="center"|1,4 kb | ||
+ | |align="center"|1,4 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"|1,2 kb | ||
+ | |align="center"| | ||
|} | |} |
Revision as of 09:30, 13 August 2008
Minipreps: Plasmid extraction
Glycerol Stocks
Results of the transformations we did yesterdayConcentration of the MiniPreps
New PCR screening with the right pimersTransformants with pFlgA, pFlgB and pFlhB cloned into J61002 are analysed by PCR but this time with the right primers (O18 and O19).
Electrophoresis
|